Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis.

Ashraf Fawzy NabhanFarida ElshafeeyLuna Marion MehrainRita KabraAmal Elshabrawy

Published in: BMC women's health (2021)

Self-injection of subcutaneous depot medroxyprogesterone acetate probably improves continuation of contraceptive use. The effects on other outcomes remain uncertain because of the very low certainty of evidence.

Keyphrases

type diabetes
metabolic syndrome
ultrasound guided
insulin resistance
weight loss